In this episode of Contagious Thinking, host Thomas Verstraeten, CEO at P95, speaks with Rodrigo DeAntonio, Population Intelligence Director and Researcher at Cevaxin by endpoints clinical Research Network. Together, they explore how Latin America has become a key player in global clinical research — from early vaccine trials for rotavirus, HPV, and pneumococcal disease to its pivotal role during the COVID-19 pandemic. The discussion highlights the region’s strengths in participant recruitment, regulatory evolution, quality standards, and cost-effectiveness, while also examining emerging opportunities in cardiometabolic diseases, neuroscience, oncology, and medical devices. Rodrigo shares insights on how collaborative networks, technology, and a favorable research environment are positioning Latin America for even greater impact in the years ahead.